Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11031349rdf:typepubmed:Citationlld:pubmed
pubmed-article:11031349lifeskim:mentionsumls-concept:C0013182lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0008717lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0600642lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:11031349lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:11031349pubmed:issue4lld:pubmed
pubmed-article:11031349pubmed:dateCreated2000-10-27lld:pubmed
pubmed-article:11031349pubmed:abstractTextThe mechanisms involved in adverse drug reactions with an immunologic basis (ADRIB) can be antibody dependent, mainly IgE or T cell dependent (sensitized T cells). These mechanisms are regulated by a number of cytokines, including IL-2, IL-4, IL-5, IFN-gamma, and TNF-alpha, which follow the classical T(H)1/T(H)2 immunologic paradigm. Although evidence for this has been seen in ex vivo studies, the results are heterogeneous, and few in vivo studies have been carried out in subjects with ADRIB.lld:pubmed
pubmed-article:11031349pubmed:languageenglld:pubmed
pubmed-article:11031349pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11031349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11031349pubmed:statusMEDLINElld:pubmed
pubmed-article:11031349pubmed:monthOctlld:pubmed
pubmed-article:11031349pubmed:issn0091-6749lld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:FernandezJJlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:RodriguezJ...lld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:JuarezCClld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:RosayBBlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:BlanckGGlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:TorresM JMJlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:BravoIIlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:LeyvaLLlld:pubmed
pubmed-article:11031349pubmed:authorpubmed-author:PosadasS JSJlld:pubmed
pubmed-article:11031349pubmed:issnTypePrintlld:pubmed
pubmed-article:11031349pubmed:volume106lld:pubmed
pubmed-article:11031349pubmed:ownerNLMlld:pubmed
pubmed-article:11031349pubmed:authorsCompleteYlld:pubmed
pubmed-article:11031349pubmed:pagination769-76lld:pubmed
pubmed-article:11031349pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:meshHeadingpubmed-meshheading:11031349...lld:pubmed
pubmed-article:11031349pubmed:year2000lld:pubmed
pubmed-article:11031349pubmed:articleTitleSubjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction.lld:pubmed
pubmed-article:11031349pubmed:affiliationResearch Unit for Allergic Diseases, Carlos Haya Hospital, Malaga, Spain.lld:pubmed
pubmed-article:11031349pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11031349pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11031349pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed